09.12.2019 13:15:37
|
AgeX Issues Letter To Shareholders - Quick Facts
(RTTNews) - AgeX Therapeutics, Inc. (AGE) issued a letter to shareholders on progress made by AgeX in its first year as a public company. In the letter, the company stated that it has filed numerous new patent applications and saw success in obtaining new patent issuances. To optimize shareholder value, the company has started a strategic review of its business opportunities.
Going forward, AgeX plans to strengthen its capacity of executing on external licensing and collaboration deals with third parties as well as in-house cell therapy product development.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu AgeX Therapeutics Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |